Dear Dr. Renukaprasad A R, Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for 75-85% of cases. The majority of HCCs are diagnosed in patients with cirrhosis and/or chronic hepatitis B infection, necessitating close monitoring of these groups for early tumor detection, intervention, and hence higher curative responses. For more insights, join us for an exclusive session with the renowned hepatologist, Dr. Akash Shukla and our panel of experts in our special World Liver Day Conclave session on "Case Discussions in HCC" Today, 6:00 PM IST onwards. Session Highlights - Patient Journey in HCCPrediction of TACE non-responseSynergism of systemic and loco-regional therapyRight Time to switch therapyUnfront Systemic therapy in the right candidate |
No comments:
Post a Comment